NCT05223179View on ClinicalTrials.gov

Intramuscular CodaVax-H1N1 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

April 11, 2022

Primary Completion Date

February 9, 2024

Study Completion Date

February 9, 2024

Conditions
Influenza, Human
Interventions
BIOLOGICAL

CODA-VAX H1N1

Intramuscular Live Attenuated Influenza H1N1 Vaccine

BIOLOGICAL

Flucelvax Quad

Licensed Seasonal Injectable Influenza Vaccine

OTHER

Saline

Saline

Trial Locations (1)

QLD 4556

Lis Gilmour, Senior Project Manager, Morayfield

Sponsors

Lead Sponsor

Codagenix, Inc
All Listed Sponsors
lead

Codagenix, Inc

INDUSTRY